Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)

被引：0
|
作者：
Lavin, V. [1 ]
Whitehurst, P. [2 ]
Harris, C. [2 ]
Goldstraw, R. [2 ]
Bayman, N. [1 ]
Chan, C. [1 ]
Coote, J. [1 ]
Harris, M. [1 ]
Pemberton, L. [1 ]
Sheikh, H. [1 ]
Woolf, D. [1 ]
Faivre-Finn, C. [1 ]
机构：
[1] Christie Hosp NHS Fdn Trust, Clin Oncol, BX, Manchester, Lancs, England
[2] Christie Hosp NHS Fdn Trust, Med Phys, BX, Manchester, Lancs, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [21] Stereotactic ablative radiotherapy (SABR) in medically inoperable early stage non-small cell lung cancer (NSCLC): A single tertiary UK centre experience
    Yip, C.
    Landau, D. B.
    Thomas, C.
    Ahmad, S.
    LUNG CANCER, 2013, 79 : S58 - S58
  • [22] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [23] Introduction of stereotactic ablative body radiotherapy (SABR) for early stage non-small cell Lung cancer (NSCLC) at a tertiary referral centre - the Birmingham experience
    Stevenson, R.
    Cook, M.
    Webster, G.
    Brennan, M.
    Stange, D.
    Wingate, E.
    Biard, C.
    Hickman, M.
    Ghafoor, Q.
    LUNG CANCER, 2014, 83 : S62 - S62
  • [24] Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more
    White, Abby
    Swanson, Scott J.
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S399 - S405
  • [25] Isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC) - a feasibility study
    Faivre-Finn, C.
    LUNG CANCER, 2014, 83 : S79 - S80
  • [26] Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) - a Feasibility Study
    Haslett, K.
    Bayman, N.
    Franks, K.
    Groom, N.
    Hanna, G.
    Harden, S.
    Harris, C.
    Harrow, S.
    Hatton, M.
    Mccloskey, P.
    Mcdonald, F.
    Ashcroft, L.
    Ryder, D.
    Faivre-Finn, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1838 - S1839
  • [27] Isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC) - a feasibility study
    Haslett, K.
    Ashcroft, L.
    Bayman, N.
    Franks, K.
    Groom, N.
    Hannah, G.
    Harden, S.
    Harris, C.
    Harrow, S.
    Hatton, M.
    McCloskey, P.
    McDonald, F.
    Ryder, W. D. J.
    Faivre-Finn, C.
    LUNG CANCER, 2018, 115 : S62 - S63
  • [28] Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a word of caution
    Varela, Gonzalo
    Teresa Gomez-Hernandez, Maria
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 102 - 105
  • [29] Treatment of Early Stage Non-Small Cell Lung Cancer: Surgery or Stereotactic Ablative Radiotherapy?
    Uzel, Esengul Kocak
    Abacioglu, Ufuk
    BALKAN MEDICAL JOURNAL, 2015, 32 (01) : 8 - 16
  • [30] Is stereotactic ablative radiotherapy (SABR) a safe treatment for multiple primary lung cancer (MPLC) non-small cell lung cancer (NSCLC)?
    Murray, P. F.
    Spencer, K.
    Snee, M.
    Dickinson, P.
    Jain, P.
    Clarke, K.
    Franks, K.
    LUNG CANCER, 2016, 91 : S48 - S48
12345